BOSTON, June 25, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by ...
Multiple spine surgeons have debuted endoscopic technologies and techniques since October. 30, reflecting increasing priorities in minimally invasive care. 1. Neurosurgeon Chris Talbot, DO, ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid(R) Annular Closure ...
BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid® Bone-Anchored Annular Closure ...
BOSTON, June 21, 2023 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, announced today that Cigna ...
KETTERING, Ohio (Ivanhoe Newswire) – Nine hundred thousand people undergo back surgery each year. One of the main problems? Herniated or bulging discs. In fact, half a million people remove bulges ...
Barricaid is ideally suited for the ASC setting. Using a minimally invasive technology such as Barricaid allows ASCs to instantly differentiate themselves in the market, since a majority of patients ...
Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its ...
KETTERING, Ohio (Ivanhoe Newswire) – Each year, 900,000 people undergo back surgery. One of the main problems? Herniated or bulging discs. In fact, half a million people remove bulges that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results